These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1822792)

  • 1. Dystrophin immunofluorescence pattern in manifesting and asymptomatic carriers of Duchenne's and Becker muscular dystrophies of different ages.
    Vainzof M; Pavanello RC; Pavanello I; Tsanaclis AM; Levy JA; Passos-Bueno MR; Rapaport D; Zatz M
    Neuromuscul Disord; 1991; 1(3):177-83. PubMed ID: 1822792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of dystrophin in carriers of Duchenne muscular dystrophy.
    Clerk A; Rodillo E; Heckmatt JZ; Dubowitz V; Strong PN; Sewry CA
    J Neurol Sci; 1991 Apr; 102(2):197-205. PubMed ID: 2072119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophin-associated protein abnormalities in dystrophin-deficient muscle fibers from symptomatic and asymptomatic Duchenne/Becker muscular dystrophy carriers.
    Di Blasi C; Morandi L; Barresi R; Blasevich F; Cornelio F; Mora M
    Acta Neuropathol; 1996 Oct; 92(4):369-77. PubMed ID: 8891069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers.
    Matthews PM; Benjamin D; Van Bakel I; Squier MV; Nicholson LV; Sewry C; Barnes PR; Hopkin J; Brown R; Hilton-Jones D
    Neuromuscul Disord; 1995 May; 5(3):209-20. PubMed ID: 7633186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy.
    Arahata K; Ishihara T; Kamakura K; Tsukahara T; Ishiura S; Baba C; Matsumoto T; Nonaka I; Sugita H
    N Engl J Med; 1989 Jan; 320(3):138-42. PubMed ID: 2643040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of dystrophin-associated glycoproteins and utrophin in carriers of Duchenne muscular dystrophy.
    Sewry CA; Matsumura K; Campbell KP; Dubowitz V
    Neuromuscul Disord; 1994; 4(5-6):401-9. PubMed ID: 7881285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.
    Vainzof M; Passos-Bueno MR; Pavanello RC; Schreiber R; Zatz M
    J Med Genet; 1992 Jul; 29(7):476-9. PubMed ID: 1640426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Becker muscular dystrophy: demonstration of the carrier status of a female by immunoblotting and immunostaining.
    Chevron MP; Tuffery S; Echenne B; Demaille J; Claustres M
    Neuromuscul Disord; 1992; 2(1):47-50. PubMed ID: 1525558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophin immunostaining of muscle from Chinese patients with various neuromuscular diseases.
    Jong YJ; Chuang YH; Chen SS; Chen BH; Chiang CH
    J Formos Med Assoc; 1991 Dec; 90(12):1143-8. PubMed ID: 1686882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy.
    Bushby KM; Goodship JA; Nicholson LV; Johnson MA; Haggerty ID; Gardner-Medwin D
    Neuromuscul Disord; 1993 Jan; 3(1):57-64. PubMed ID: 8329890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophin negative skeletal and myocardial muscle cells in a carrier of Duchenne's muscular dystrophy.
    Watanabe K; Izumi T; Natsui M; Matsubara N; Miyakita Y; Koyama S; Inomata T; Suzuki M; Shibata A
    Eur Heart J; 1993 Jul; 14(7):989-92. PubMed ID: 8375425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
    Mizuno Y; Nonaka I; Hirai S; Ozawa E
    J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy.
    Bonilla E; Schmidt B; Samitt CE; Miranda AF; Hays AP; de Oliveira AB; Chang HW; Servidei S; Ricci E; Younger DS
    Am J Pathol; 1988 Dec; 133(3):440-5. PubMed ID: 3059802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
    Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
    Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophin abnormalities in Duchenne and Becker dystrophy carriers: correlation with cytoskeletal proteins and myosins.
    Mora M; Morandi L; Piccinelli A; Gussoni E; Gebbia M; Blasevich F; Dworzak F; Cornelio F
    J Neurol; 1993 Sep; 240(8):455-61. PubMed ID: 8263549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
    Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
    J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy.
    Haginoya K; Yamamoto K; Iinuma K; Yanagisawa T; Ichinohasama Y; Shimmoto M; Suzuki Y; Tada K
    J Neurol; 1991 Oct; 238(7):375-8. PubMed ID: 1683669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport.
    Barbiroli B; Funicello R; Iotti S; Montagna P; Ferlini A; Zaniol P
    J Neurol Sci; 1992 Jun; 109(2):188-95. PubMed ID: 1634901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.